At Sirtex, we value the time and effort all prospective candidates have taken to express interest in working at Sirtex. Our process aims to ensure that all applicants are treated with respect and are acknowledged for their application. Sirtex is an equal opportunity/affirmative action employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, colour, religion, national origin, disability, protected Veteran status, age, or any other characteristic protected by law.


Open positions at:


Region: Americas
Location: Wilmington, MA

Advertising Date: Thu 06 May 2021


Region: Americas
Location: Los Angeles CA

Advertising Date: Thu 06 May 2021


Region: Europe, Middle East and Africa
Location: Europe

Advertising Date: Thu 06 May 2021


Region: Americas
Location: Woburn MA

Advertising Date: Wed 05 May 2021


Region: Europe, Middle East and Africa
Location: London UK

Advertising Date: Thu 29 April 2021


Region: Europe, Middle East and Africa
Location: Italy

Advertising Date: Thu 29 April 2021


Region: Americas
Location: Woburn MA

Advertising Date: Fri 23 April 2021


Region: Americas
Location: Wilmington Ma

Advertising Date: Fri 16 April 2021


Region: Americas
Location: Wilmington MA

Advertising Date: Tue 13 April 2021


Region: Americas
Location: Woburn MA

Advertising Date: Tue 13 April 2021


Region: Americas
Location: Woburn MA

Advertising Date: Fri 09 April 2021


Region: Americas
Location: Woburn MA

Advertising Date: Tue 06 April 2021


Region: Americas
Location: Woburn MA

Advertising Date: Fri 02 April 2021


Region: Americas
Location: Chicago Il

Advertising Date: Mon 29 March 2021


Region: Americas
Location: Chicago Il

Advertising Date: Wed 24 March 2021


Region: Americas
Location: Wilmington, MA

Advertising Date: Thu 18 March 2021


Region: Americas
Location: Woburn MA

Advertising Date: Thu 18 March 2021


Region: Americas
Location: Woburn MA

Advertising Date: Fri 12 March 2021


Region: Asia Pacific
Location: Hong Kong

Advertising Date: Wed 06 January 2021


Now leaving sirtex.com

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.

Continue

×

Now leaving sirtex.com

You are about to leave the Sirtex Website. This link is provided to you as a service and will take you to the Sirtex Virtual Booth.

Sirtex is responsible for the content of the Virtual Booth, which is hosted on a website maintained by a third-party. Except for Sirtex’s Virtual Booth experience, please be aware that Sirtex takes no responsibility for the other content of these external sites, nor do we endorse, warrant, or guarantee the products, services or information described or offered on other internet sites.

Continue

×

You are now leaving your current sirtex.com region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.

Continue

×

Effective May 7, 2021, SIR-Spheres will have the following indication for use:
SIR-Spheres Y-90 resin microspheres are indicated for the treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy.

Ok